NeuroOne Seeks Again FDA Clearance For sEEG Electrode In Brain Mapping Diagnostics
NeuroOne Medical Technologies (NASDAQ: NMTC) has submitted a special 510(k) to the U.S. Food and Drug Administration (FDA) for its sEEG electrode to extend the duration of use from less than 24 hours to less than 30 day use.
